SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-017460
Filing Date
2023-11-02
Accepted
2023-11-02 17:07:57
Documents
56
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20230930x10q.htm   iXBRL 10-Q 1703632
2 EX-10.1 ptgx-20230930xex10d1.htm EX-10.1 99251
3 EX-31.1 ptgx-20230930xex31d1.htm EX-31.1 10160
4 EX-31.2 ptgx-20230930xex31d2.htm EX-31.2 10150
5 EX-32.1 ptgx-20230930xex32d1.htm EX-32.1 10130
6 GRAPHIC ptgx-20230930x10q006.jpg GRAPHIC 93490
  Complete submission text file 0001558370-23-017460.txt   6511532

Data Files

Seq Description Document Type Size
7 EX-101.SCH ptgx-20230930.xsd EX-101.SCH 39417
8 EX-101.CAL ptgx-20230930_cal.xml EX-101.CAL 50013
9 EX-101.DEF ptgx-20230930_def.xml EX-101.DEF 129603
10 EX-101.LAB ptgx-20230930_lab.xml EX-101.LAB 304692
11 EX-101.PRE ptgx-20230930_pre.xml EX-101.PRE 237804
50 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20230930x10q_htm.xml XML 1092570
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 231373482
SIC: 2834 Pharmaceutical Preparations